Otsuka Holdings
4578.T
$40.62
Share price
1.56%
Change (1 day)
20.36%
Change (1 year)
Categories
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.
Operating Margin for Otsuka Holdings (4578.T)
Operating Margin as of April 2024 (TTM): 12.03%
According to Otsuka Holdings 's latest financial reports and stock price the company's current Operating Margin is 12.03%. At the end of 2022 the company had an Operating Margin of 9.95%.
Operating Margin history for Otsuka Holdings from 2010 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 9.95% | -8.89% |
| 2021 | 10.92% | -18.21% |
| 2020 | 13.35% | 7.45% |
| 2019 | 12.43% | 46.63% |
| 2018 | 8.48% | 1.33% |
| 2017 | 8.36% | -14.3% |
| 2016 | 9.76% | 2.08% |
| 2015 | 9.56% | -33.93% |
| 2014 | 14.47% | -0.38% |
| 2013 | 14.53% | 17.77% |
| 2012 | 12.33% | 10.88% |
| 2011 | 11.12% | 18.32% |
| 2010 | 9.40% | -0.27% |
| 2009 | 9.43% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.